These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 19048211

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Short hairpin RNA-expressing bacteria elicit RNA interference in mammals.
    Xiang S, Fruehauf J, Li CJ.
    Nat Biotechnol; 2006 Jun; 24(6):697-702. PubMed ID: 16699500
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bacterial delivery of RNAi effectors: transkingdom RNAi.
    Lage H, Krühn A.
    J Vis Exp; 2010 Aug 18; (42):. PubMed ID: 20811323
    [Abstract] [Full Text] [Related]

  • 6. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y, Nishikawa M, Takakura Y.
    Adv Drug Deliv Rev; 2009 Jul 25; 61(9):760-6. PubMed ID: 19386274
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.
    Zheng JN, Pei DS, Mao LJ, Liu XY, Mei DD, Zhang BF, Shi Z, Wen RM, Sun XQ.
    Cancer Gene Ther; 2009 Jan 25; 16(1):20-32. PubMed ID: 18690204
    [Abstract] [Full Text] [Related]

  • 8. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
    Zhang Y, Boado RJ, Pardridge WM.
    J Gene Med; 2003 Dec 25; 5(12):1039-45. PubMed ID: 14661179
    [Abstract] [Full Text] [Related]

  • 9. Optimized gene silencing by co-expression of multiple shRNAs in a single vector.
    Ishigaki Y, Nagao A, Matsunaga T.
    Methods Mol Biol; 2010 Dec 25; 623():109-21. PubMed ID: 20217547
    [Abstract] [Full Text] [Related]

  • 10. Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA.
    Wang SL, Yao HH, Guo LL, Dong L, Li SG, Gu YP, Qin ZH.
    Cancer Genet Cytogenet; 2009 Apr 01; 190(1):8-14. PubMed ID: 19264227
    [Abstract] [Full Text] [Related]

  • 11. Development of a novel nonviral gene silencing system that is effective both in vitro and in vivo by using a star-shaped block copolymer (star vector).
    Mori T, Ishikawa A, Nemoto Y, Kambe N, Sakamoto M, Nakayama Y.
    Bioconjug Chem; 2009 Jun 01; 20(6):1262-9. PubMed ID: 19456093
    [Abstract] [Full Text] [Related]

  • 12. Inducible RNA interference-mediated gene silencing using nanostructured gene delivery arrays.
    Mann DG, McKnight TE, McPherson JT, Hoyt PR, Melechko AV, Simpson ML, Sayler GS.
    ACS Nano; 2008 Jan 01; 2(1):69-76. PubMed ID: 19206549
    [Abstract] [Full Text] [Related]

  • 13. TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.
    Keates AC, Fruehauf J, Xiang S, Li CJ.
    Biotechnol Genet Eng Rev; 2008 Jan 01; 25():113-27. PubMed ID: 21412352
    [Abstract] [Full Text] [Related]

  • 14. Strategies for short hairpin RNA delivery in cancer gene therapy.
    Wang SL, Yao HH, Qin ZH.
    Expert Opin Biol Ther; 2009 Nov 01; 9(11):1357-68. PubMed ID: 19761417
    [Abstract] [Full Text] [Related]

  • 15. Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeutics.
    Keates AC, Fruehauf JH, Xiang S, Parker PD, Li CJ.
    Pharmacogenomics; 2007 Jul 01; 8(7):867-71. PubMed ID: 18240911
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O, Legrand N, von Eije KJ, Centlivre M, Spits H, Weijer K, Blom B, Berkhout B.
    Gene Ther; 2009 Jan 01; 16(1):148-53. PubMed ID: 18668146
    [Abstract] [Full Text] [Related]

  • 17. RNA interference: a novel and physiologic mechanism of gene silencing with great therapeutic potential.
    Calderón AJ, Lavergne JA.
    P R Health Sci J; 2005 Mar 01; 24(1):27-33. PubMed ID: 15895874
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. RNA interference based gene therapy for neurological disease.
    Jagannath A, Wood M.
    Brief Funct Genomic Proteomic; 2007 Mar 01; 6(1):40-9. PubMed ID: 17478451
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.